RDB06777 - pEF-BOSneo-Myc-MINT (1-3576)-FLAG

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions for distribution	RECIPIENT shall use the BIOLOGICAL RESOURCE only for academic research for the purpose of publishing the research results. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must obtain a prior written consent from the Kyoto University Medical Science and Business Liaison Organization Liaison Office (contracts@kumbl.med.kyoto-u.ac.jp). In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by DEPOSITOR (Kuroda, K., Immunity, 18, 301-312, 2003) and an acknowledgment to Depositor are requested. When requested by the DEPOSITOR, RIKEN BRC informs the DEPOSITOR on the name of resource, RECIPIENT's name and his/her affiliation, purpose of the use, and number of resources. Additional terms and conditions: Regarding pEF-BOS and pEF-BOS-EX vectors: The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. RECIPIENT shall contact Dr. Shigekazu Nagata in the case of any commercial use of the pEF-BOS or pEF-BOS-EX vectors. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature designated by Dr. Shigekazu Nagata (Mizushima S. and Nagata S.I, Nucleic Acids Res. 18: 5322, 1990) and an acknowledgment to Dr. Shigekazu Nagata are requested.
Ordering	Order form [Credit Card Payment] [Bank Transfer Payment] MTA, for use for not-for-profit academic purpose [Word] MTA, for use for for-profit purpose [Word] Please visit Information of Request for Distribution.[link]

Terms and conditions for distribution

RECIPIENT shall use the BIOLOGICAL RESOURCE only for academic research for the purpose of publishing the research results. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must obtain a prior written consent from the Kyoto University Medical Science and Business Liaison Organization Liaison Office (contracts@kumbl.med.kyoto-u.ac.jp). In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by DEPOSITOR (Kuroda, K., Immunity, 18, 301-312, 2003) and an acknowledgment to Depositor are requested. When requested by the DEPOSITOR, RIKEN BRC informs the DEPOSITOR on the name of resource, RECIPIENT's name and his/her affiliation, purpose of the use, and number of resources.
Additional terms and conditions:
Regarding pEF-BOS and pEF-BOS-EX vectors: The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. RECIPIENT shall contact Dr. Shigekazu Nagata in the case of any commercial use of the pEF-BOS or pEF-BOS-EX vectors. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature designated by Dr. Shigekazu Nagata (Mizushima S. and Nagata S.I, Nucleic Acids Res. 18: 5322, 1990) and an acknowledgment to Dr. Shigekazu Nagata are requested.

Ordering

Order form [Credit Card Payment

] [Bank Transfer Payment

]
MTA, for use for not-for-profit academic purpose [Word

]
MTA, for use for for-profit purpose [Word

]
Please visit Information of Request for Distribution.[link]

提供案内 (日本国内)

[open/close]

提供条件	本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。公表を前提とした学術研究に限る。営利機関の利用者は、事前に京都大学・「医学領域」産学連携推進機構・知財室 (contracts@kumbl.med.kyoto-u.ac.jp) に連絡し、承諾を得ること。利用者は、研究成果の公表にあたって寄託者の指定する文献(Kuroda, K., Immunity, 18, 301-312, 2003)を引用し、寄託者への謝辞の表明を必要とする。理研BRCは、本件リソースのリソース名、提供先、利用目的、件数を京都大学・本庶佑教授に報告する。付加的提供条件： pEF-BOS and pEF-BOS-EXベクターについて: 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。利用者が、pEF-BOSおよびpEF-BOS-EXベクターを商業的に利用する場合、利用者は長田重一教授に連絡するものとする。利用者は、研究成果の公表にあたって長田重一教授の指定する文献 (Mizushima S. and Nagata S.I, Nucleic Acids Res. 18: 5322, 1990.)を引用し、長田重一教授への謝辞の表明を必要とする。
提供依頼	提供依頼書 [Word] 提供同意書 (MTA, 非営利学術目的用)[Word] 提供同意書 (MTA, 営利目的用)[Word] 手続きの概要は、「提供申込みについて[link]」をご覧ください。

提供条件

本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。公表を前提とした学術研究に限る。営利機関の利用者は、事前に京都大学・「医学領域」産学連携推進機構・知財室 (contracts@kumbl.med.kyoto-u.ac.jp) に連絡し、承諾を得ること。利用者は、研究成果の公表にあたって寄託者の指定する文献(Kuroda, K., Immunity, 18, 301-312, 2003)を引用し、寄託者への謝辞の表明を必要とする。理研BRCは、本件リソースのリソース名、提供先、利用目的、件数を京都大学・本庶佑教授に報告する。
付加的提供条件：
pEF-BOS and pEF-BOS-EXベクターについて: 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。利用者が、pEF-BOSおよびpEF-BOS-EXベクターを商業的に利用する場合、利用者は長田重一教授に連絡するものとする。利用者は、研究成果の公表にあたって長田重一教授の指定する文献 (Mizushima S. and Nagata S.I, Nucleic Acids Res. 18: 5322, 1990.)を引用し、長田重一教授への謝辞の表明を必要とする。

提供依頼

提供依頼書 [Word

]
提供同意書 (MTA, 非営利学術目的用)[Word

]
提供同意書 (MTA, 営利目的用)[Word

]
手続きの概要は、「提供申込みについて[link]」をご覧ください。

How to cite this biological resource

Tips

QC test results

Catalog #	Resource name	Shipping form	Fee (non-profit org.)
RDB06777	pEF-BOSneo-Myc-MINT (1-3576)-FLAG	DNA solution

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check

icon as well as clone information before placing your order.

pEF-BOSneo-Myc-MINT (1-3576)-FLAG

Distribution information

How to cite this biological resource

Tips

QC test results

References

Primer: pAxEF_F1 Sequence file: RDB13107_A5B3a.seq
>06777_13107_A5B3_pAxEF_F1_E01_13.ab1 1 CTTTTTTCGT TCATTTCAGG TGTCGTGAGG AATTCTCTAG CCTCGACGCC ACCATGGAGC 61 AAAAGCTCAT TTCTGAAGAG GACTTGGGAG ACCGAGACCT CCGCACGGAT TATAATGAGC 121 CAGGAACTAT TCCGAGTGCT GCCCGGGGAC TGGACGAGAC AGTTTCCATA GCGTCTCGTA 181 GTAGAGAGGT TTCTGGGTTC AGAGGAAGTG CTGGAGGGCC TGCTTATGGT CCCCCACCAT 241 CACTTCATGC ACGAGAAGGA CGCTATGAGC GGAGACTCGA TGGGGCTTCA GATAACAGGG 301 AGCGTGCTTA TGAACATAGT GCCTATGGAC ACCATGAACG GGGGACAGGA GCATTTGATC 361 GGACAAGACA TTACGATCAG GATTACTATA GAGACCCTCG AGAGCGGACT TTACAACACG 421 GGCTCTATTA CACTTCTCGG AGTCGAAGTC CAAACCGCTT TGATGCTCAT GACCCCCGAT 481 ACGAACCTAG GGCCCGGGAG CAGTTTACAC TGCCCAGTGT GGTACACAGG GATATCTACA 541 GGGACGACAT TACCCGGGAG GTACGAGGCA GAAGGCCAGA GCGCAGTTAC CAACACAGCA 601 GGAGTCGCTC ACCACATTCG TCCCAGTCTA GAAACCAGTC CCCGCAGAGG CTGGCTAGCC 661 AAGCGTCCAG ACCCACCAGG TCCCCCAGCG GCAGCGGCTC CAGGAGTCGA TCCTCCAGTA 721 GTGACTCCAT CAGCAGCAGC AGCAGCAGCA GCAACACTGA CAGTAGCGAC TCCAGCAGCA 781 CGGCCAGTGA CGACTCTCCG GCCCGCTCTG TTCAGTCGGC TGCAGTCCCC GCACCCACTT 841 CCCAGTTGCT TTCGTCCCTT GAAAAAGATG AGCCCCGGAA AAGTTTTGGG ATCAAAGTTC 901 AGAATCTTCC AGTACGCTCT ACAGACACAA GCCTTAAAGA CGGCCTTTTC CATGAGTTTA 961 AGAAGTTTGG CAAGGTGACG TCAGTGCAGA TCCACGGGGG CCCTCCGAGG GAGAGATACG 1021 GGCCTGGTGT TTCTTTCCGG GCAGCAAGAG GGACCCAAGA AAAAGCATTT GACCCGCATC 1081 CCGAGGGGGA AGCTCTTCTT TCGGGCCATG GCAGATCGAG TTGAACTTGC CAATGGGTTA 1141 GAACCAAGCA AACAGGAGGA GTGTGAAAAA TGTGAGAGTT TTTTTCG //
Primer: hGCSF-R Sequence file: RDB13107_A5B3b.seq
>06777_13107_A5B3_hGCSF-R_F01_16.ab1 1 CTGGAACTGA TCTCTCAGGG TCCCAGGTGG GGACCCTCAC TCTAGGATAT CATCTAGACG 61 GATCCGCAAT TGGCCCGGCC GCTCTAGACT ACTTGTCATC GTCGTCCTTG TAATCCACCG 121 AGGCAATGAC AATCATGAGG TGAGGAGAGA TGTTGGAGAT GCTGGCAAGG AGGTCAGGGG 181 CCAGCCGGGA GAGGTGACTC TCGGAGAACT CACAGGGTGG GAAGATCTGA AGCACGTAGG 241 CAGGCTGATT GGAGCCAGGG TTGGGGACAT TGATAATCCC TGCTGCTTGC TTGGCCTGCA 301 GGTAAGTGAT GAAGGCAGCC TTGAGGGACT CGGTCTGGCT CACCACATCC TCCTGGTCAC 361 GGCCACAGGG CAGAGCCAGC AGCAGGCAGT AGTCGGTTTC CACTGTCATT CTCCTGGCGA 421 CCCCTTCCAG CTGTGAGGCC TCTAGTCGCA TCCTCTGGGC GATCCGCAGT GGGGGACCAC 481 CTTCAGAGAG AGGCAGGGAC CGATGAGCCA GGACATTGTT GCCAGAGACG AAGTGGAGCT 541 GCACAGCAGC CGTGTCGTTC TTGAGGGCCA GCAGGCCCTG CCACACGATG GGGTACTTCT 601 TCAGCAGCTG GACCATATCC ACAGGCCGTT GTGGTGTCCC GTGTGGAGAA GACTCTTGTT 661 TGGGAGCTGG CTGGACTTCA GCGTGAGGCA GAGCCAGTCC AGGTGGGGTG CTTGGGCCTG 721 AGTTTGCAGG GACAAACAAT GGCTGCTTTG GGGCAGCCTG AGAGGAAAGA GGGCTTGGGA 781 GGTCTGGCTT CATGGAGACG GACACAGGGG AGGGGTGGGC TGGCTGGGCT GTTTCCACCG 841 GCGCCCTCTG AAGCTGAGCG TGTGGCTCAG ATGGCCTGTT TGTGGGGATG GCTGGGAGGC 901 GAGTCTGCTC CACCCCTCCT GTCTGCGTCC CCTTTGCTTC TTGGGAGACC TGAGGAATCT 961 TGCCACTCGG TGGCTGGGCA GGCTGGCTGA GTTGGGAGGG CTGGCAGGGC GGGGCAGGTG 1021 GTATAGGCTG CGTGGGCCTG CGTAGAGGGG GCAGGCTGTG CAGACTGCGT GGACTGCAAA 1081 GGCTCACCCT TCAGGGGCAC TGAGCCAGAA GTTCTTTGGA TCCTGGAAGG CCTTTAAGGC 1141 TGTGAATGTG GGAAAGCGA //